Haemophilia A Clinical Trials

10 recruiting

Frequently Asked Questions

Common questions about Haemophilia A clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 1

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

Haemophilia A
Novo Nordisk A/S30 enrolled22 locationsNCT07220564
Recruiting
Phase 3

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

Haemophilia A
Sinocelltech Ltd.36 enrolled1 locationNCT07437404
Recruiting

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

Haemophilia ACongenital Bleeding Disorder
Novo Nordisk A/S900 enrolled7 locationsNCT06574984
Recruiting
Phase 3

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Severe Haemophilia A
Swedish Orphan Biovitrum104 enrolled22 locationsNCT06716814
Recruiting
Phase 1

A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People

Haemophilia A
Novo Nordisk A/S80 enrolled1 locationNCT07238816
Recruiting

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

Haemophilia A
Octapharma200 enrolled55 locationsNCT03695978
Recruiting

An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct

Haemophilia A
Novo Nordisk A/S100 enrolled1 locationNCT05621746
Recruiting

A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI

Haemophilia A
Haemophilia Centre Rhine Main300 enrolled1 locationNCT02207894
Recruiting

Prevalence of Synovitis in Patients With Haemophilia A

Haemophilia ASynovitisHemophilia Arthropathy+1 more
University Hospital, Bonn300 enrolled1 locationNCT06352216
Recruiting

The Haemophilia Osteoporosis Registry (THOR): Identifying Mechanisms of Bone Loss in Haemophilia

Haemophilia ASarcopeniaOsteoporosis+1 more
Monash University176 enrolled2 locationsACTRN12621001397808
Recruiting

Balance, strength and related falls risk factors in people with haemophilia and other bleeding disorders (PWH), and feasibility of a targeted home exercise program to improve balance.

Haemophilia and other bleeding disorders
Haemophilia Foundation of Australia60 enrolled1 locationACTRN12606000172505